Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chenxiang Qu for functional dyspepsia with postprandial distress syndrome
ChiCTR1900024909Phase 4Not yet recruiting
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Sep 2018
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of chenxiang qu in functional dyspepsia (FD) (2 arms), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoint: Upper abdominal distension, early satiety and belching severity score. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
chenxiang qu
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR1900024909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024909.